DOI: https://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20222074
Published: 2022-08-25

Comparative real world clinical assessment of fixed dose combination of mometasone and fusidic acid cream versus fluticasone and mupirocin ointment in the management of atopic dermatitis with secondary bacterial infection

Indur Ramchandani, Namrata Mahadkar, Dhiraj S. Dhoot, Hanmant Barkate

Abstract


Background: Bacterial skin infections caused by gram positive bacteria are mostly encountered in paediatric age group. These infections are found to commonly complicate atopic dermatitis with prevalence of 80-100%, and are treated with fixed dose combination (FDC) of topical corticosteroids and antibiotics.

Methods: This retrospective study was conducted in patients ≥2 years of age with a diagnosis of atopic dermatitis with secondary bacterial infections and having investigator’s global assessment score of 2 or 3. Patient’s clinical outcomes were analysed on the basis of skin infection rating scale (SIRS) wherein each of signs/symptom were rated on scale of 0 to 3.

Results: The 206 patients had received FDC of mometasone and fusidic acid (MF) and 159 patients had received fluticasone and mupirocin (FM). Percentage of patients achieving complete clearance of symptoms/signs was higher in MF group as compared to FM. Percentage of patients achieving clinical success were significantly higher with mometasone. Recurrences and percentage of patients with clinical failure were higher in FP group. 

Conclusions: Effectiveness of MF FDC was significant as compared to FM, FDC in terms of complete clearance of lesions, increased number of patients achieving clinical success and less number of recurrences.

 


Keywords


Mometasone, Fluticasone, FDC, Secondary bacterial infections

Full Text:

PDF

References


Vayalumkal JV, Jadavji T. Children hospitalized with skin and soft tissue infections. A guide to antibacterial selection and treatment. Pediatr Drugs. 2006;8:99-111.

Gottlieb T, Atkins BL, Shaw DR. Soft tissue, bone and joint infections. Med J Aust. 2002;176:609-15.

Palit A, Inamadar AC. Current concepts in the management of bacterial skin infections in children. Indian J Dermatol Venereol Leprol. 2010;76(5):476-88.

Khobragade KJ. Efficacy and safety of combination ointment "fluticasone propionate 0.005% plus mupirocin 2.0%" for the treatment of atopic dermatitis with clinical suspicion of secondary bacterial infection: an open label uncontrolled study. Indian J Dermatol Venereol Leprol. 2005;71(2):91-5.

Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy, Asthma Immunol. 2021;126(1):3-12.

Wachs GN, Maibach HI. Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginized atopic dermatitis. Br J Dermatol. 1976;95(3):323-8.

Velappan R, Ramasamy S, Venu S, Chandrasekar M. A randomised open label comparative study evaluating the effectiveness, adherence and safety between 2% mupirocin ointment and 2% fusidic acid cream in children with impetigo. Int J Res Dermatol. 2019;5(3):1-6.

Gilbert M. Topical 2% Mupirocin versus 2% Fusidic acid ointment in the treatment of primary and secondary skin infection Randomised controlled trial. J Am Acad Dermatol. 1989;20(6):1083-7.

Morley PA, Munot LD. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis, Randomised controlled trial. Curr Med Res Opin. 1988;11(2):142-8.

Vasani RJ, Medhekar SV. Topical 2% mupirocin versus 2% fusidic acid versus 1% nadifloxacin cream in the treatment of superficial bacterial infections of the skin. Indian J Drugs Dermatol. 2015;1:16-8.

Reddy JV, Rao AV, Madhavulu B, Kudagi BL, Mohan PR. A randomised open label parallel group study comparing the safety, effectiveness and adherence between 2% fusidic acid cream versus 1% retapamulin ointment in children with impetigo. Int J Basic Clin Pharmacol. 2019;8:446-52.

Kharkar RD, Dhoot D, Mahajan H, Barkate H. A real-world retrospective analysis of comparison of effectiveness and safety of mometasone furoate and fluticasone propionate in the management of eczema and dermatitis. IP Indian J Clin Exp Dermatol 2021;7(2):120-4.